Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Shares Outstanding (Weighted Average) (2016 - 2025)

BioCorRx (BICX) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $24.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 134.03% to $24.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Dec 2025, up 134.03% year-over-year, with the annual reading at $24.5 million for FY2025, 134.03% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $24.5 million in Q4 2025 for BioCorRx, up from $20.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $24.5 million in Q4 2025 to a low of $6.0 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $10.1 million across 5 years, with a median of $8.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 8.0% in 2022 and later soared 134.03% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $6.5 million in 2021, then increased by 10.9% to $7.2 million in 2022, then grew by 15.92% to $8.3 million in 2023, then grew by 25.41% to $10.5 million in 2024, then soared by 134.03% to $24.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BICX at $24.5 million in Q4 2025, $20.2 million in Q3 2025, and $16.1 million in Q2 2025.